SCHEMBL770526

SCHEMBL770526

NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCC(=O)N1CCCC2CCCCC21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.49
MEN1 O00255 1/20 0.49
HCRTR1 O43613 1/20 0.49
KMT2A Q03164 1/20 0.49
F10 P00742 1/20 0.48
DPP4 P27487 1/20 0.47
ECE1 P42892 2/20 0.46
TACR1 P25103 1/20 0.46
HPGDS O60760 1/20 0.45
OPRM1 P35372 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ITGB2 P05107 1/20 0.45
ICAM1 P05362 1/20 0.45
ITGAL P20701 1/20 0.45
EPHX2 P34913 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL770240 0.83 ACE (0.54) ALDH1A1EPHX2
SCHEMBL770809 0.83 ACE (0.54) ALDH1A1EPHX2
SCHEMBL15386652 0.83 ACE (0.54) ALDH1A1EPHX2
SCHEMBL15245679 0.81 ALDH1A1 (0.64) MEN1KMT2AKDM4EALDH1A1L3MBTL1
SCHEMBL26424521 0.80 MEN1 (0.64) MEN1HCRTR1KMT2AECE1HPGDS
SCHEMBL24024006 0.79 MEN1 (0.62) MEN1HCRTR1KMT2AECE1HPGDS
SCHEMBL15245360 0.79 KMT2A (0.62) MEN1KMT2AKDM4EALDH1A1L3MBTL1
SCHEMBL15245659 0.78 BCHE (0.56) BCHEDPP4TACR1ITGB2ICAM1
SCHEMBL26414216 0.77 MEN1 (0.63) MEN1HCRTR1KMT2AECE1HPGDS
SCHEMBL18684577 0.77 BCHE (0.58) BCHEMEN1KMT2ADPP4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 BCHE 278/4885MEN1 827/4885HCRTR1 244/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 BCHE 291/4885MEN1 823/4885HCRTR1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.